Senti Biosciences enters equity commitment letter with Cpif II-9 on Nov. 9, 2026
SNTI•Senti Biosciences entered an equity commitment letter with Cpif II-9 on Nov. 9; Cpif II-9 may purchase up to $4.55 million of the company’s common stock.
1. Equity commitment
A Nov. 10 SEC filing says Senti Biosciences entered an equity commitment letter with Cpif II-9 on Nov. 9, 2026. Under the letter, Cpif II-9 is to purchase up to $4.55 million of Senti Biosciences common stock.
